| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/25/2001 | US6294560 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/22/2001 | CA2341344A1 Use of glycogen phosphorylase inhibitors |
| 09/20/2001 | WO2001068650A1 Perylene-derivative based crystallization modifiers |
| 09/20/2001 | WO2001068649A1 Novel process for the preparation of a quinoline carboxylic acid derivative having a 7-(4-aminomethyl-3-oxime)pyrrolidine substituent |
| 09/20/2001 | WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases |
| 09/20/2001 | WO2001068625A1 Method for the production of spirocyclic tetronic acid derivatives |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068588A1 POLYMER-IMMOBILIZED α-IMINOESTER |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | DE10013188A1 New hydrogenated perylenetetracarboxylic dianhydride, diimide and anhydride-imide derivatives are used as crystallization modifiers for organic pigments and in perylene pigment formulations |
| 09/20/2001 | DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/19/2001 | EP1134217A2 Cosmetic composition containing a furan-naphthoquinone derivative, use therof as dyeing agent, and derivatives |
| 09/19/2001 | EP1134215A1 2-oxo-imidazolidine-4-carboxylic acid hydroxamine compounds that inhibit matrix metalloproteinases |
| 09/19/2001 | CN1313859A Preparation of camptothecin and nothapodytine derivatives |
| 09/19/2001 | CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof |
| 09/19/2001 | CN1071117C Antitussive |
| 09/18/2001 | US6291684 Process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| 09/18/2001 | US6291681 Reacting meso-2,3-bis(benzylamino)succinic acid dialkali metal salt with phenyl chloroformate; acidification, isolating 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidinedicarboxylic acid; heating with acetic anhydride to produce anhydride compound |
| 09/18/2001 | US6291676 As antiproliferative agent |
| 09/18/2001 | US6291483 Administering a therapeutically effective amount of berberine or a pharmaceutically acceptable salt thereof |
| 09/18/2001 | US6291475 Bispidine antiarrhythmic compounds |
| 09/18/2001 | US6291472 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo[3′,4′:4, 5]furo[3,2-b] pyri-dine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation |
| 09/18/2001 | US6291470 Indole derivatives process for producing the same and medicinal uses of the same |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/17/2001 | CA2341840A1 Cosmetic composition comprising a furan-naphthoquinone derivative, its use as a coloring agent and derivatives |
| 09/13/2001 | WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO1997014683A3 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 09/13/2001 | US20010021791 Cyclopropyl phenyl ketone compound |
| 09/13/2001 | US20010021777 Indane or dihydroindole derivatives |
| 09/13/2001 | CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/12/2001 | EP1131325A1 [pyrrole]naphthopyranes, their preparation, compositions and (co)polymer matrices containing them |
| 09/12/2001 | EP1131322A2 Dihydropyridine compounds and methods of use |
| 09/12/2001 | EP1131306A2 Isoxazoline fibrinogen receptor antagonists |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | CN1312804A Macrocyclic analogs and methods of their use and preparation |
| 09/11/2001 | US6288185 Initiators for radical polymerization |
| 09/11/2001 | US6288102 Substituted phenylketoenols and their use as pesticides and herbicides |
| 09/11/2001 | US6288099 Compounds such as 8-bromo-10h-benzo(4,5)furo(3,2-b)indole-1-carboxylic acid used to treat disorders associated with smooth muscle contration such as urinary incontinence and irritable bowl syndrome |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288081 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 09/11/2001 | US6288073 Acronycine derivatives, preparation method and pharmaceutical compositions |
| 09/11/2001 | US6288072 Anticarcinogenic and antitumor agents; leukemia |
| 09/11/2001 | US6288059 Acylated hetero-alicyclic derivatives |
| 09/11/2001 | US6288058 Treating muscular, nervous system, psychological and gastrointestinal disorders |
| 09/11/2001 | US6288057 Physical form of dihydro-2,3-benzodiazepine derivative |
| 09/07/2001 | WO2001064692A1 Cardioprotective phosphonates and malonates |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064670A1 Novel cyclic amide derivatives |
| 09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001064650A2 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 09/07/2001 | WO2001064635A1 Ningalin b analogs employable for reversing multidrug resistance |
| 09/07/2001 | WO2001064213A1 Compounds and methods |
| 09/07/2001 | CA2401800A1 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 09/07/2001 | CA2401673A1 Ningalin b analogs employable for reversing multidrug resistance |
| 09/07/2001 | CA2400649A1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/06/2001 | WO2001064715A2 Memno peptides, a process for their preparation and their use |
| 09/06/2001 | US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/06/2001 | US20010020101 Process for preparing biotin |
| 09/06/2001 | US20010020095 High affinity for D4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 09/06/2001 | US20010020093 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermeidate |
| 09/06/2001 | US20010020027 Using 1-(4-(1-(4-fluorophenyl)-1H-indole-3-yl)-1-butyl spiro(isobenzofuran-1(3H,4-piperidine) |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/05/2001 | EP1130027A1 Memno peptides, process for preparation and use thereof |
| 09/05/2001 | EP1130021A2 Pyrrolopyridinium derivatives |
| 09/05/2001 | EP1130016A1 Thiocarbamic acid derivatives |
| 09/05/2001 | EP1129076A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 09/05/2001 | CN1311778A Fused-heterocycle dicarboxylic diamide derivatives of salts thereof, herbicides and usage thereof |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 09/05/2001 | CN1311773A Neuropeptide Y5 receptor antagonists |
| 09/05/2001 | CN1311678A Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 09/05/2001 | CN1070493C Heterocyclic condensed furanpyranoid ring compound and herbicides |
| 09/04/2001 | US6284891 Intermediates such as 4-ethyl-1h-pyrano(3,4-c)pyridin-8-one; or 4-ethyl-7-(7-iodo-9-((4-methyl-piperazinyl)methyl) -2,3-dihydro-(1,4)dioxino(2,3-g)quinolin-8-ylmethyl)-1h-pyrano (3,4-c)pyridin-8-one. |
| 09/04/2001 | US6284769 Nonpeptide kappa opioid receptor antagonists |
| 09/04/2001 | US6284764 Antiproliferative agent |
| 08/30/2001 | WO2001062761A1 Method of preparing alkaloids using supercritical fluids from plants |
| 08/30/2001 | WO2001011968A3 Heterocyclic spiro compounds as pesticides |
| 08/30/2001 | US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/30/2001 | US20010018441 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents |
| 08/29/2001 | EP1127879A1 Preparation of 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidin dicarboxylic acid and its anhydrid |
| 08/29/2001 | EP1127872A1 Tamiflu via Diels-Alder |
| 08/29/2001 | EP1127051A2 Tricyclic pyrazole derivatives |
| 08/29/2001 | EP0828741B1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| 08/29/2001 | EP0819108B1 Process for preparing galanthamine derivatives by asymmetric reduction |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310712A Phenylazole compound, process for producing the same and drugs for hyperlipemia |
| 08/29/2001 | CN1310706A Inhibitors of phospholipase enzymes |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310621A Substituted anilide compounds and methods |
| 08/29/2001 | CN1310176A Production of cyclic acid |
| 08/29/2001 | CN1310170A Process for producing 4,5-diamino shikimic acid derivative |
| 08/29/2001 | CN1309964A Carbazole-alkoloid cell cycle inhibitor, cell death inducer and their preparation |
| 08/28/2001 | US6281355 Nitrogen-containing tetracyclic compounds |